Balaxi Pharmaceuticals Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BALAXI.NS | BALPHARMA.NS | 2348.HK | LUP.F | SANJIVIN.BO | LP6.F | |
|---|---|---|---|---|---|---|
| Market cap | 1.21B | 1.33B | 1.38B | 762.19M | 2.17B | 2.33B |
| P/E (TTM) | 48.6 | 18.4 | 5.4 | 18.8 | 29.1 | 11.9 |
| Forward P/E | — | — | 2.1 | — | — | — |
| Price/book | 0.5 | 1.6 | 0.3 | 0.4 | 4.1 | 1.3 |
| Dividend yield | — | 1.46% | 6.89% | — | — | 7.18% |
| 1-year change | −52.65% | +2.23% | −22.46% | −47.69% | −16.90% | −23.98% |
| Today | +6.78% | +1.72% | 0.00% | +3.87% | +1.61% | +0.77% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All BALAXI.NS news ›Balaxi Pharmaceuticals BALAXI RTA Report Physical Share Transfers
Balaxi Pharmaceuticals (NSE:BALAXI): What Does the RTA Report on Physical Share Transfers Mean? Kalkine India Balaxi Pharmaceuticals (NSE:BALAXI): What Does the RTA Report on Physical Share Transfers Mean? Source: Krish Capital Pty Ltd…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkine.co.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.